Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Medtronic (MDT – Research Report), with a ...

A strategic analysis commissioned by the county led board members to the decision to look at the best healthcare options ...

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

Shares of Medtronic PLC MDT advanced 1.52% to $89.47 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...

In April, Medtronic obtained FDA approval for another new product, Inceptiv, a spinal cord stimulator for treating chronic pain. The device can automatically adjust the therapy — a unique feature — to ...

The robot maker plans to conduct clinical trials for several indications, including abdominal, pelvis, thoracic and cardiac procedures.

JPMorgan Chase is in talks to take over Apple's credit-card program from Goldman Sachs, potentially impacting both ...

SS Innovations today issued an update on the FDA approval timeline for its Mantra surgical robotic system following meetings with the agency.